Texas Heart Institute Cardiometabolic Syndrome Conference 2024

Comprehensive Multidisciplinary Update on Cardiometabolic Syndrome, Obesity, Diabetes, Fatty Liver Disease, and Cardiovascular Risk Reduction

Overview

The Texas Heart Institute Cardiometabolic Syndrome Conference 2024 is a multidisciplinary educational program focused on the growing global burden of Cardiometabolic Syndrome (CMS) and its impact on cardiovascular disease, diabetes, obesity, fatty liver disease, cancer, and chronic inflammatory disorders.

This conference brings together experts from cardiology, endocrinology, hepatology, gastroenterology, rheumatology, pulmonology, neurology, internal medicine, and surgery to address the complex interactions between metabolic dysfunction and chronic disease. The program emphasizes evidence-based management strategies while exploring innovative solutions that extend beyond traditional healthcare approaches, including social determinants of health, community partnerships, nutrition interventions, and population health initiatives.

Through 20 expert-led lectures, participants gain practical insights into screening, prevention, treatment, and long-term management of cardiometabolic disease.

Course Specifications

Format

• 20 Video Lectures

Course Year

2024

Educational Level

Intermediate to Advanced

Specialty

Cardiometabolic Medicine

Learning Objectives

Upon completion of this activity, participants should be able to:

• Define cardiometabolic syndrome and its clinical implications.
• Apply guideline-based screening strategies for cardiometabolic disease.
• Implement evidence-based treatment approaches for obesity, diabetes, and dyslipidemia.
• Recognize the relationship between cardiometabolic syndrome and non-cardiac diseases.
• Evaluate the impact of social determinants of health on disease outcomes.
• Utilize nutrition-based interventions for cardiovascular risk reduction.
• Address cardiometabolic disease in pediatric populations.
• Integrate multidisciplinary approaches into clinical practice.

Core Topics Covered

Cardiometabolic Syndrome Fundamentals

Topics Include

• Definition of Cardiometabolic Syndrome
• Epidemiology
• Disease Burden
• Healthcare Costs
• Global Trends
• Future Projections

Participants review the growing prevalence and consequences of CMS worldwide.

Obesity and Metabolic Disease

Topics Include

• Obesity Pathophysiology
• Adipose Tissue Dysfunction
• Metabolic Inflammation
• Weight Management Strategies
• Obesity as a Chronic Disease
• Long-Term Treatment Approaches

Review of obesity as a central driver of cardiometabolic dysfunction.

Type 2 Diabetes and Insulin Resistance

Topics Include

• Insulin Resistance
• Prediabetes
• Type 2 Diabetes Mellitus
• Glycemic Control
• Cardiovascular Risk Reduction
• Emerging Therapies

Participants learn contemporary approaches to diabetes prevention and management.

Cardiovascular Disease and CMS

Topics Include

• Atherosclerotic Cardiovascular Disease (ASCVD)
• Coronary Artery Disease
• Stroke Prevention
• Heart Failure
• Vascular Disease
• Cardiovascular Risk Stratification

Focus on reducing cardiovascular morbidity and mortality in high-risk populations.

Hypertension Management

Topics Include

• Blood Pressure Control
• Resistant Hypertension
• Risk Assessment
• Lifestyle Interventions
• Pharmacologic Therapy

Review of current hypertension guidelines and management strategies.

Dyslipidemia and Lipid Disorders

Topics Include

• LDL Cholesterol Management
• Hypertriglyceridemia
• Residual Cardiovascular Risk
• Statin Therapy
• Novel Lipid-Lowering Agents

Participants review contemporary lipid management practices.

Fatty Liver Disease and Metabolic Dysfunction

A major focus of the conference.

Topics Include

• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
• Nonalcoholic Fatty Liver Disease (NAFLD)
• Nonalcoholic Steatohepatitis (NASH)
• Liver Fibrosis
• Cardiovascular Risk in Liver Disease
• Emerging Treatments

The conference highlights the growing relationship between metabolic disease and chronic liver disorders.

Cardiometabolic Syndrome and Cancer

Topics Include

• Obesity-Associated Malignancies
• Chronic Inflammation
• Metabolic Risk Factors
• Cancer Prevention Strategies

Review of emerging evidence linking CMS to cancer development.

Pediatric Cardiometabolic Disease

Topics Include

• Childhood Obesity
• Pediatric Insulin Resistance
• Early Cardiovascular Risk
• Prevention Strategies
• Long-Term Outcomes

Participants explore the increasing burden of CMS among children and adolescents.

Nutrition as Therapy

Topics Include

• Food as Medicine
• Therapeutic Nutrition
• Dietary Counseling
• Weight Reduction
• Cardiovascular Risk Modification
• Community-Based Nutrition Programs

Special emphasis is placed on prescribing nutrition as part of comprehensive treatment plans.

Social Drivers of Health

Topics Include

• Health Equity
• Access to Care
• Socioeconomic Determinants
• Community Health Initiatives
• Population-Based Prevention

Participants learn how social factors contribute to cardiometabolic disease progression.

Innovative Models of Care

Topics Include

• Community Partnerships
• Preventive Health Programs
• Public Health Interventions
• Multidisciplinary Care Teams
• Population Health Management

Review of novel approaches to reducing the burden of CMS.

Rheumatologic and Inflammatory Disorders

Topics Include

• Chronic Inflammation
• Autoimmune Disease
• Cardiovascular Risk in Rheumatologic Conditions
• Metabolic Dysfunction

Exploration of the relationship between inflammation and cardiometabolic disease.

Pulmonary Manifestations of CMS

Topics Include

• Obstructive Sleep Apnea
• Obesity Hypoventilation Syndrome
• Pulmonary Hypertension
• Respiratory Consequences of Obesity

Neurologic Consequences

Topics Include

• Stroke Risk
• Cognitive Impairment
• Vascular Dementia
• Neurovascular Disease

Review of neurologic complications associated with metabolic disease.

Educational Features

Multidisciplinary Faculty

Features experts from cardiology, endocrinology, hepatology, gastroenterology, rheumatology, pulmonology, neurology, and surgery.

Population Health Perspective

Focuses on both individual patient care and broader public health approaches.

Evidence-Based Guidelines

Reviews contemporary recommendations for screening, diagnosis, and treatment.

Innovative Prevention Strategies

Explores novel approaches to reversing the growing burden of cardiometabolic disease.

Target Audience

Physicians

• Cardiologists
• Internists
• Endocrinologists
• Hepatologists
• Gastroenterologists
• Rheumatologists
• Pulmonologists
• Neurologists
• Surgeons
• Family Medicine Physicians

Advanced Practice Providers

• Nurse Practitioners
• Physician Assistants

Allied Health Professionals

• Nurses
• Dietitians
• Diabetes Educators
• Public Health Professionals

Trainees

• Residents
• Fellows
• Medical Students

Why Choose This Course?

• Comprehensive review of cardiometabolic syndrome.
• Strong focus on obesity, diabetes, and cardiovascular disease.
• Includes emerging links between CMS, liver disease, and cancer.
• Addresses social determinants of health and population health strategies.
• Multidisciplinary faculty from numerous specialties.
• Emphasizes innovative approaches beyond traditional medical treatment.

 Topics:

• An Employer Perspective on Community Health Initiatives.mp4
  Behavior Change and Health Outcomes in the Age of AI.mp4
  Cardiometabolic Syndrome in Children A Sign of Things To Come.mp4
  Cardiometabolic Syndrome in Women.mp4
  Changing Dietary Habits at the Population Level.mp4
  Defining the Epidemiologic Scope of Cardiometabolic Syndrome.mp4
  From Streets to Heartbeats Urban Environment and Cardiometabolic Health.mp4
  Impact of Contemporary Therapies on CMS.mp4
  Implementation Science to Improve Patient Engagement and Leveraging Systems to Enhance Care.mp4
  Leveraging Community Resources to Support Mental Health in the Workplace.mp4
  Looking at Community Health Trends with Survey Data The Greater Houston Community Panel.mp4
  National Priorities on Lifestyle and Cardiometabolic Health.mp4
  Opening Plenary Session Panel Discussion Q&A.mp4
  Research and Community Health Priorities Panel Discussion Q&A.mp4
  Technology & Digital Health Innovations Non-Medical Management Panel Discussion Q&A.mp4
  The Role of Local and State Governments.mp4
  Using Big Data to Understand and Treat Cardiometabolic Syndrome.mp4
  We Have the Tools, It’s Time To Unite The Intersection of CMH & MASLD MASH.mp4
  We Know What To Do. Why Isn’t It Working.mp4
  What the Guidelines Tell Us About Cardiometabolic Syndrome.mp4